In a patient with mild leukocytosis (WBC 16 ×10⁹/L) and neutrophilia (ANC 13.12 ×10⁹/L), what is the clinical significance of slight poikilocytosis and a slight increase in elliptocytes on the peripheral blood smear?

Clinical Significance of Slight Poikilocytosis and Elliptocytes with Leukocytosis

In a patient with mild leukocytosis (WBC 16 ×10⁹/L) and neutrophilia (ANC 13.12 ×10⁹/L), slight poikilocytosis with elliptocytes is most likely a reactive finding secondary to an acute inflammatory or infectious process and does not indicate a primary hematologic disorder.

Interpretation Framework

The combination of findings you describe—mild leukocytosis with neutrophilia alongside slight red cell morphologic changes—points toward a reactive process rather than a primary bone marrow disorder. Here's the algorithmic approach:

Step 1: Assess the Leukocytosis Pattern

Your patient has:

• WBC 16 ×10⁹/L (mild elevation)
• ANC 13.12 ×10⁹/L (neutrophilia)

This degree of leukocytosis with neutrophil predominance is most consistent with infection, inflammation, or physiologic stress 1. The neutrophilia is proportionate and not extreme, making primary myeloproliferative disorders or leukemia less likely.

Step 2: Interpret the Red Cell Morphology

Slight poikilocytosis with elliptocytes in this context is a nonspecific finding. The key considerations:

• Reactive changes: Sepsis and severe infections can cause erythrocyte morphological changes, including poikilocytosis 2. When inflammatory processes are severe enough to cause leukocytosis, they can also affect red cell morphology through oxidative stress and membrane damage.

• Not indicative of MDS: For myelodysplastic syndromes, you would expect more pronounced dysplastic features across multiple cell lines, not just slight poikilocytosis 3, 4. MDS diagnosis requires significant dysplasia in >10% of cells in affected lineages, bone marrow evaluation, and typically presents with cytopenias—not leukocytosis 4.

Step 3: Clinical Context Matters

Look for these specific clinical features:

Infectious/inflammatory causes to evaluate:

• Fever, localizing signs of infection
• Recent surgery or trauma
• Soft tissue infections (can cause both leukocytosis and RBC morphologic changes) 2
• Inflammatory conditions

Laboratory parameters to check:

• Hemoglobin and MCV (to assess for anemia or iron deficiency)
• Inflammatory markers (CRP, procalcitonin if sepsis suspected)
• Peripheral smear review for blast cells (should be absent)

Step 4: What This Is NOT

This presentation does NOT suggest:

• Myelodysplastic syndrome: Would show cytopenias, not leukocytosis, plus more pronounced dysplasia 4
• Chronic myeloid leukemia: Would show marked leukocytosis (typically >25-50 ×10⁹/L) with left shift
• Primary hereditary elliptocytosis: Would show moderate-to-marked elliptocytes (>25-50%), not slight changes

Common Pitfalls to Avoid

1. Over-interpreting mild morphologic changes: Slight poikilocytosis is nonspecific and can occur in many reactive conditions. Don't trigger extensive hematologic workup for minimal findings in the setting of obvious infection/inflammation.

2. Ignoring the complete clinical picture: The leukocytosis with neutrophilia provides the key context—this is a reactive picture, not a primary marrow disorder.

3. Unnecessary bone marrow biopsy: Not indicated when you have leukocytosis (not cytopenia), no blasts, and only slight morphologic changes in a clinically appropriate context.

Recommended Action

Monitor and treat the underlying condition causing the leukocytosis. Repeat CBC after resolution of the acute process:

• If morphology normalizes → confirms reactive etiology
• If poikilocytosis persists with normal counts → consider hereditary causes or chronic conditions
• If cytopenias develop or worsen → then consider hematology referral for possible MDS evaluation

The slight elliptocytes and poikilocytosis are incidental findings that do not change management in this clinical scenario of reactive leukocytosis.